Tissue Diagnostics Market
Global Tissue Diagnostics Market Size, Share & Trends Analysis Report, By Technology (Immunohistochemistry, In-Situ Hybridization, H&E Stain, Special Staining, Digital Pathology, and Others), By Diagnosis (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Carcinoma and Others), By Product (Instrument (Slide Staining Systems, Scanners, Tissue Processing Systems, and Others) and Consumables (Antibody, Kits, Reagents, Probes, and Others)), By End-User (Hospitals & Clinics, Laboratories & Research Institutes, and Others), Forecast (2022-2028) Update Available - Forecast 2024-2030
The global tissue diagnostics market is anticipated to grow at a considerable CAGR of 6.4% during the forecast period. The need for more accurate diagnosis in cases of cancer has resulted in the development of more advanced diagnostic technologies such as tissue diagnostics. Cancer is a fatal disease and it is prevalent across the globe with a huge economic burden in emerging and low-middle income group countries. It has a considerable presence in developed and developing economies such as the US, UK, Spain, China, India, and Korea. Tissue diagnosis includes Haematoxylin & Eosin (H&E) Stain, Immunohistochemistry (IHC) Test, Fluorescent in Situ Hybridization (FISH) Test, Silver in Situ Hybridization (SISH) Test, Pathology, and other stain tests. These diagnostic services are widely available and due to technological advancement, innovation and efficient results these diagnostic devices are in huge demand.
Impact of COVID-19 Pandemic on Global Tissue Diagnostics Market
During COVID-19, many countries had been impacted by the pandemic, and the governments of these countries had ordered nationwide lockdowns which shut down operations of various industries. Additionally, the global tissue diagnostic market was also impacted by the COVID-19 pandemic due to the operational halt of the market players due to lockdowns. However, the surge in the rising number of patients requiring tissue diagnosis presented lucrative growth opportunities for the growth of the market during the COVID-19 pandemic.
Segmental Outlook
The global tissue diagnostic market is segmented based ontechnology, diagnosis, product and end-user. Based on the technology, the market is segmentedinto immunohistochemistry, in-situ hybridization, h&e stain, special staining, digital pathology and others. Based on the diagnosis, the market is sub-segmented intobreast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung carcinoma and others. Based on product, the market is segmented into instruments (slide staining systems, scanners, tissue processing systems and others) and consumables (antibody, kits, reagents, probes and others). Based on the end-user, the market is segmented into hospitals & clinics, laboratories & research institutes, and others.
Global Tissue Diagnostics Market Share by Product, 2021 (%)
Consumable Holds a Prominent Share in the Global Tissue Diagnostics Market.
Based on the product, the consumables are expected to grow at a significant rate during the forecast period. This is attributed to their increasing requirement in large numbers as well as cost-effectiveness along with ease of use. Additionally, the growth of the consumables segment is also due to the increasing number of reagent rental agreements.
Regional Outlook
The global tissue diagnostics market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Germany, Italy, Spain, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). North America is anticipated to grow during the forecast period due to the Easy accessibility to advanced technologies as well as government initiatives for screening cancer patients in the region.
Global Tissue Diagnostics Market Growth by Region, 2022-2028
Asia-Pacific Region Holds a Prominent Share in the Global Tissue Diagnostics Market.
The Asia-Pacific region holds a prominent share in the tissue diagnostics market. The major factor driving the growth of the market in the region due to high prevalence of cancer. Asia-Pacific countries such as China, India, Japan, and Korea are the key markets and are expected to improve upon their existing diagnostic technologies. Additionally, improved healthcare spending, infrastructure, and favorable government policies are the key factors that are expected to drive the market in the region.
Market Players Outlook
The major companies serving the global tissue diagnostics market include Abbott Laboratories, F. Hoffmann-La Roche AG, Bio-Genex Laboratories, Bio SB Inc., and Agilent Technologies among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, partnerships, geographical expansion and collaborations to stay competitive in the market. For instance, in August 2019, Roche announced the expanded use of the VENTANA PD-L1 (SP142) Assay3,4 in triple-negative breast cancer for patients living in CE (ConformitéEuropéene) markets.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global tissue diagnostics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1.Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on the Global Tissue Diagnostics Market
- Recovery Scenario of Global Tissue Diagnostics Market
1.1.Research Methods and Tools
1.2.Market Breakdown
1.2.1.By Segments
1.2.2.By Region
2.Market Overview and Insights
2.1.Scope of the Report
2.2.Analyst Insight & Current Market Trends
2.2.1.Key Findings
2.2.2.Recommendations
2.2.3.Conclusion
3.Competitive Landscape
3.1.Key Company Analysis
3.2.Key Strategy Analysis
3.3.Impact of Covid-19 on Key Players
4.Market Segmentation
4.1.Global Tissue Diagnostics Market by Technology
4.1.1.Immunohistochemistry
4.1.2.In-Situ Hybridization
4.1.3.H&E Stain
4.1.4.Special Staining
4.1.5.Digital Pathology
4.1.6.Others
4.2.Global Tissue Diagnostics Market by Diagnosis
4.2.1.Breast Cancer
4.2.2.Gastric Cancer
4.2.3.Lymphoma
4.2.4.Prostate Cancer
4.2.5.Non-Small Cell Lung Carcinoma
4.2.6.Others
4.3.Global Tissue Diagnostics Market by Product
4.3.1.Instrument
4.3.2.Consumables
4.4.Global Tissue Diagnostics Market by End-User
4.4.1.Hospitals & Clinics
4.4.2.Laboratories & Research Institutes
4.4.3.Others
5.Regional Analysis
5.1.North America
5.1.1.United States
5.1.2.Canada
5.2.Europe
5.2.1.UK
5.2.2.Germany
5.2.3.Italy
5.2.4.Spain
5.2.5.France
5.2.6.Rest of Europe
5.3.Asia-Pacific
5.3.1.China
5.3.2.India
5.3.3.Japan
5.3.4.South Korea
5.3.5.Rest of Asia-Pacific
5.4.Rest of the World
6.Company Profiles
6.1.Agilent Technologies
6.2.Allengers Medical Systems Ltd.
6.3.AliveCor Inc.
6.4.Becton, Dickinson & Company
6.5.Bio SB Inc.
6.6.Biocept
6.7.Bio-Genex Laboratories
6.8.bioMérieux SA
6.9.Caris Life Science
6.10.Cell Signalling Technology, Inc.
6.11.Danaher Corp.
6.12.Eurogentec
6.13.GE Healthcare
6.14.Grifols Diagnostic Solutions Inc.
6.15.F. Hoffmann-La Roche AG
6.16.Johnson & Johnson
6.17.Novodiax Inc.
6.18.Koninklijke Philips N.V.
6.19.Prometheus Laboratories
6.20.Quest Diagnostics
6.21.Siemens AG
6.22.Stryker Corp.
1.GLOBAL TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
2.GLOBAL TISSUE DIAGNOSTICS BY IMMUNOHISTOCHEMISTRY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3.GLOBAL TISSUE DIAGNOSTICS BY IN-SITU HYBRIDIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4.GLOBAL TISSUE DIAGNOSTICS BY H&E STAIN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5.GLOBAL TISSUE DIAGNOSTICS BY SPECIAL STAIN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6.GLOBAL TISSUE DIAGNOSTICS BY DIGITAL PATHOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7.GLOBAL TISSUE DIAGNOSTICS BY OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8.GLOBAL TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
9.GLOBAL TISSUE DIAGNOSTICS FOR BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10.GLOBALTISSUE DIAGNOSTICS FOR GASTRIC CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11.GLOBALTISSUE DIAGNOSTICS FOR LYMPHOMA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12.GLOBALTISSUE DIAGNOSTICS FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13.GLOBALTISSUE DIAGNOSTICS FOR NON-SMALL CELL LUNGCARCINOMA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14.GLOBALTISSUE DIAGNOSTICS FOR OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15.GLOBAL TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
16.GLOBALTISSUE DIAGNOSTICS BY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17.GLOBAL TISSUE DIAGNOSTICS BY CONSUMABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
18.GLOBAL TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
19.GLOBAL TISSUE DIAGNOSTICS FOR HOSPITALS & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
20.GLOBAL TISSUE DIAGNOSTICS FOR LABORATORIES & RESEARCH INSTITUES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
21.GLOBAL TISSUE DIAGNOSTICS FOR OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
22.GLOBAL TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
23.NORTH AMERICAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
24.NORTH AMERICAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
25.NORTH AMERICAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
26.NORTH AMERICAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
27.NORTH AMERICAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
28.EUROPEAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
29.EUROPEAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
30.EUROPEAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
31.EUROPEAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
32.EUROPEAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
33.ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
34.ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
35.ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
36.ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
37.ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
38.REST OF THE WORLD TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
39.REST OF THE WORLD TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
40.REST OF THE WORLD TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY, 2021-2028 ($ MILLION)
41.REST OF THE WORLD TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
1.IMPACT OF COVID-19 ON GLOBALTISSUE DIAGNOSTICS MARKET, 2021-2028 ($ MILLION)
2.IMPACT OF COVID-19 ON GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3.RECOVERY OF GLOBAL TISSUE DIAGNOSTICS MARKET, 2022-2028 (%)
4.GLOBAL TISSUE DIAGNOSTICS MARKET SHARE BY TECHNOLOGY, 2021 VS 2028 (%)
5.GLOBAL TISSUE DIAGNOSTICS BY IMMUNOHISTOCHEMISTRY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6.GLOBAL TISSUE DIAGNOSTICS BY IN-SITU HYBRIDIZATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7.GLOBAL TISSUE DIAGNOSTICS BY H&E STAIN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8.GLOBAL TISSUE DIAGNOSTICS BY SPECIAL STAINING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9.GLOBAL TISSUE DIAGNOSTICS BY DIGITAL PATHOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10.GLOBAL TISSUE DIAGNOSTICS BY OTHER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11.GLOBAL TISSUE DIAGNOSTICS MARKET SHARE BY DIAGNOSIS, 2021 VS 2028 (%)
12.GLOBAL TISSUE DIAGNOSTICS FOR BREAST CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13.GLOBAL TISSUE DIAGNOSTICS FOR GASTRIC CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14.GLOBAL TISSUE DIAGNOSTICS FOR LYMPHOMA MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15.GLOBAL TISSUE DIAGNOSTICS FOR PROSTATE CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16.GLOBAL TISSUE DIAGNOSTICS FOR NON-SMALL CELL LUNG CARCINOMA MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17.GLOBAL TISSUE DIAGNOSTICS FOR OTHER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18.GLOBAL TISSUE DIAGNOSTICS MARKET SHARE BY PRODUCT, 2021 VS 2028 (%)
19.GLOBAL TISSUE DIAGNOSTICS BY INSTRUMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
20.GLOBAL TISSUE DIAGNOSTICS BY CONSUMABLES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
21.GLOBAL TISSUE DIAGNOSTICS MARKET SHARE BY END-USER, 2021 VS 2028 (%)
22.GLOBAL TISSUE DIAGNOSTICS FOR HOSPITALS & CLINICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
23.GLOBALTISSUE DIAGNOSTICS FOR LABORATORIES & RESEARCH INSTITUES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
24.GLOBALTISSUE DIAGNOSTICS FOR OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
25.GLOBAL TISSUE DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
26.US TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
27.CANADA TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
28.UKTISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
29.FRANCE TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
30.GERMANY TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
31.ITALY TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
32.SPAIN TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
33.REST OF EUROPE TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
34.INDIA TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
35.CHINA TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
36.JAPAN TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
37.SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
38.REST OF ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
39.REST OF THE WORLD TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
